• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Sarcopenia & GLP-1 Medications: A Not So Silent Epidemic

Publication
Article

Though an effective tool for weight loss, GLP-1 medications do not distinguish between fat and muscle. Without a comprehensive nutrition plan including high-quality protein GLP-1 users may experience significant loss of skeletal muscle mass and strength that is detrimental to their health. Resistance training is also essential to support healthy muscle and healthier habits to prevent recidivism.

Download this brochure on Sarcopenia and reach out to us to learn how to help people achieve Quality Weight Loss while learning Healthier Habits.

Complete the form to download the brochure.

Sponsored by